Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress

Abstract

Cells are constantly subjected to various types of endogenous and exogenous stressful stimuli, which can cause serious and even permanent damage. The ability of a cell to sense and adapt to environmental alterations is thus vital to maintain tissue homeostasis during development and adult life. Here, we review some of the major phenotypic characteristics of the hostile tumour microenvironment and the emerging roles of extracellular vesicles in these events.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 110

1. 1.

   Kültz D. Molecular and evolutionary basis of the cellular stress response. Ann Rev Physiol. 2005;67:225-57.

   Not in our library10.1146/annurev.physiol.67.040403.103635

2. 2.
   Cellular Stress Responses: Cell Survival and Cell Death · 2010

   No notice
3. 3.

   Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res. 2011;1:98-110.

   Not in our library

4. 4.

   De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. Cell Stress Chaperones. 2011;16:235-49.

   Not in our library10.1007/s12192-010-0236-4

5. 5.

   Policastro LL, Ibañez IL, Notcovich C, Duran HA, Podhajcer OL. The tumor microenvironment: characterization, redox considerations, and novel approaches for reactive Oxygen species-targeted gene therapy. Antioxid Redox Signal.

   Not in our library10.1089/ars.2011.4367

6. 6.

   Paget S. The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev. 1989;8:98-101.

   Not in our library

7. 7.

   Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011;17:1359-70.

   Not in our library10.1038/nm.2537

8. 8.

   Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392-401.

   Not in our library10.1038/nrc1877

9. 9.

   de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6:24-37.

   Not in our library10.1038/nrc1782

10. 10.

    Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012;196:395-406.

    Not in our library10.1083/jcb.201102147

11. 11.

    Lorger M. Tumor microenvironment in the brain. Cancers. 2012;4:218-43.

    Not in our library10.3390/cancers4010218

12. 12.

    Gillies RJ, Verduzco D, Gatenby RA. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer. 2012;12:487-93.

    Not in our library10.1038/nrc3298

13. 13.

    Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11:393-410.

    Not in our library10.1038/nrc3064

14. 14.

    Bertout JA, Patel SA, Simon MC. The impact of O2 availability on human cancer. Nat Rev Cancer. 2008;8:967-75.

    Not in our library10.1038/nrc2540

15. 15.

    Chiche J, Brahimi-Horn MC, Pouysségur J. Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med. 2010;14:771-94.

    Not in our library10.1111/j.1582-4934.2009.00994.x

16. 16.

    McCarty MF, Whitaker J. Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev. 2010;15:264-72.

    Not in our library

17. 17.

    Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, et al. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science. 2009;325:1555-9.

    Not in our library10.1126/science.1174229

18. 18.
    Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison · 2012

    No notice
19. 19.

    Shieh AC. Biomechanical forces shape the tumor microenvironment. Ann Biomed Eng. 2011;39:1379-89.

    Not in our library10.1007/s10439-011-0252-2

20. 20.

    Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol. 2011;29:235-71.

    Not in our library10.1146/annurev-immunol-031210-101324

21. 21.

    Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6:715-27.

    Not in our library10.1038/nri1936

22. 22.

    Wind NS, Holen I. Multidrug resistance in breast cancer: from in vitro models to clinical studies. Int J Breast Cancer. 2011;2011:967419.

    Not in our library10.4061/2011/967419

23. 23.
    Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death · 2012

    No notice
24. 24.

    Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res. 2012;72:4875-82.

    Not in our library10.1158/0008-5472.can-12-2217

25. 25.

    D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front Physiol. 2012;3:294.

    Not in our library10.3389/fphys.2012.00294

26. 26.

    van Doormaal FF, Kleinjan A, Di Nisio M, Büller HR, Nieuwland R. Cell-derived microvesicles and cancer. Neth J Med. 2009;67:266-73.

    Not in our library

27. 27.

    Friend C, Marovitz W, Henie G, Henie W, Tsuei D, Hirschhorn K. Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res. 1978;38:2581-91.

    Not in our library

28. 28.

    Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2010;59:841-50.

    Not in our library10.1007/s00262-009-0808-2

29. 29.

    Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13-21.

    Not in our library10.1016/j.ygyno.2008.04.033

30. 30.

    Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94:3791-99.

    Not in our library

31. 31.

    Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161-72.

    Not in our library10.1084/jem.183.3.1161

32. 32.

    Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9:581-93.

    Not in our library10.1038/nri2567

33. 33.

    Savina A, Fader CM, Damiani MT, Colombo MI. Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner. Traffic. 2005;6:131-43.

    Not in our library10.1111/j.1600-0854.2004.00257.x

34. 34.

    Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12:19-30.

    Not in our library10.1038/ncb2000

35. 35.

    Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA, et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010;189:223-32.

    Not in our library10.1083/jcb.200911018

36. 36.

    Yu X, Harris SL, Levine AJ. The regulation of exosome secretion: a novel function of the p53 protein. Cancer Res. 2006;66:4795-801.

    Not in our library10.1158/0008-5472.can-05-4579

37. 37.

    Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244-7.

    Not in our library10.1126/science.1153124

38. 38.

    Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14:677-85.

    Not in our library10.1038/ncb2502

39. 39.

    Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006;172:923-35.

    Not in our library10.1083/jcb.200508014

40. 40.

    Lenassi M, Cagney G, Liao M, Vaupotic T, Bartholomeeusen K, Cheng Y, et al. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic. 2010;11:110-22.

    Not in our library10.1111/j.1600-0854.2009.01006.x

Cited by papers we hold 10

• Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review · 2022
  No notice
• Exosomes and Their Noncoding RNA Cargo Are Emerging as New Modulators for Diabetes Mellitus · 2019
  No notice
• Mechanisms associated with biogenesis of exosomes in cancer · 2019
  No notice
• Clinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung Diseases · 2018
  No notice
• Role of exosomal proteins in cancer diagnosis · 2017
  No notice
• MicroRNA in Glioblastoma: An Overview · 2017
  No notice
• Exosomes in Cancer Diagnostics · 2017
  No notice
• Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer · 2015
  No notice
• Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia · 2014
  No notice
• Exosome in Tumour Microenvironment: Overview of the Crosstalk between Normal and Cancer Cells · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.